SALT LAKE CITY, Oct. 14, 2020 /PRNewswire/ — Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced it will present results from studies suggesting that low testosterone levels may play an important role on the clinical outcomes of COVID-19 in men as well as the safety and efficacy of TLANDO™, an oral testosterone replacement therapy without a dose titration requirement, at the 21st Annual Fall Scientific Meeting of the Sexual Medicine Society of North America (“SMSNA”). Lipocine will outline the possible mechanisms and clinical evidence that suggests men with low testosterone have poor COVID-19 outcomes, and the rationale of using an oral testosterone therapy for men with COVID-19. Results from the previously completed dose validation (“DV”) study of a fixed dose TLANDO in hypogonadal males will also be presented at the meeting. The presentations will take place virtually on November 9, 2020
Office Politics: The Art Of The Possible
Playing politics is like having sex. Almost everybody does it, but nobody is comfortable discussing exactly what they do. We will talk for hours, however, about what other people might be doing. Typically, we use the term “playing politics” only to describe our colleagues’ behavior – never our own. They are sucking up, scheming, and manipulating, but we are building relationships, developing strategies, and opening communication channels.
The above paragraph was quoted from Dr. Marie McIntyre’s recent book, “Secrets to Winning at Office Politics”. And it’s true! When people are placed together in a corporation (or in a family, or a reality TV island), it is human nature to compete for power, influence, rewards, and recognition. How people carry out this competition, and the value individuals place on the spoils, are what we call office politics.
Ignore politics at your peril! A sure … Read More